Supplementary protection
LT - Pirolo[2,3-d]pirimidino dariniai kaip proteino kinazės B slopikliai
EN - PYRROLO[2,3-D]PYRIMIDIN DERIVATIVES AS PROTEIN KINASE B INHIBITORS
SPC
| (11) |
Number of the document |
C 2201012 |
| (68) |
Number of the document |
2201012
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2024 532 |
| (22) |
Date of filing the application |
2024-11-13 |
| (41) |
Date of publication of the application |
2024-12-10 |
|
Date of publication of SPC |
2025-12-10 |
| (24) |
Date of coming into effect of SPC |
2028-10-10 |
Applicant
| (71) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
Grantee
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
Attorney or representative
| (74) |
Ramunė GARŠVIENĖ,
Dūkštų g. 28-20, LT-07171 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/24/1820, 2024-06-17
|
Calculated date of expiry of the SPC
| (94) |
2033-10-09 |
Name of the product protected by the basic patent
| (95) |
Kapivasertibas ir jo farmaciniu požiūriu priimtina druska |
